BioNxt Solutions Inc. (OTCMKTS:BNXTF) Short Interest Update

BioNxt Solutions Inc. (OTCMKTS:BNXTF) saw a significant growth in short interest in the month of January. As of January 15th, there was short interest totalling 4,700 shares, a growth of 6.8% from the December 31st total of 4,400 shares. Based on an average daily volume of 6,700 shares, the short-interest ratio is presently 0.7 days.

BioNxt Solutions Trading Down 3.3 %

OTCMKTS:BNXTF opened at $0.27 on Tuesday. The firm has a market capitalization of $30.72 million, a price-to-earnings ratio of -6.77 and a beta of 0.69. BioNxt Solutions has a 1-year low of $0.11 and a 1-year high of $0.51. The business’s fifty day moving average price is $0.25 and its 200 day moving average price is $0.20.

BioNxt Solutions (OTCMKTS:BNXTF) last issued its earnings results on Friday, November 29th. The company reported ($0.01) EPS for the quarter.

About BioNxt Solutions

BioNxt Solutions Inc engages in generation drug formulations and delivery system in Korea, Austria, Germany, and Switzerland. The company provides drug delivery methods, such as transdermal patches and oral dissolvable films designed for delivery of neurological medications. It offers point-of-care diagnostic, including covid-19 PCR diagnostic kit, a covid rapid test; peri-implantitis Oral Biosensor, allows early detection of infection associated with dental implants; and H1N1 (Swine Flu) and H5N1 (Avian Flu) oral biosensors for early detection of highly pathogenic influenza a strains.